Table 1 Characteristics of the participants with DVHD
|  | Without AF (n = 60) | With AF (n = 52) | P |
|---|---|---|---|
Age, years, mean ± SD | 71.9 ± 6.9 | 72.9 ± 5.9 | 0.829 |
Age > 75, n (%) | 21 (35) | 22(42) | 0.443 |
Male, n (%) | 31 (40.3) | 28 (53.8) | 0.703 |
Type of DVHD, n (%) | |||
 Aortic valve | 16 (26.7) | 19 (36.5) | 0.157 |
 Mitral valve | 15 (25) | 13 (25) | 0.175 |
 Aortic valve and mitral valve | 29 (48.3) | 20 (38.4) | 0.134 |
Body mass index, kg/m2, mean ± SD | 25.2 ± 2.2 | 24.6 ± 2.3 | 0.806 |
Fasting blood glucose, mmol/L, mean ± SD | 5.9 ± 1.1 | 5.7 ± 1.0 | 0.825 |
TG, mmol/L, mean ± SD | 1.7 ± 1.0 | 1.7 ± 1.0 | 0.813 |
TC, mmol/L, mean ± SD | 4.4 ± 1.1 | 4.5 ± 1.1 | 0.820 |
SBP, mmHg, mean ± SD | 129.5 ± 10.2 | 126.3 ± 13.6 | 0.792 |
DBP, mmHg, mean ± SD | 68.3 ± 7.0 | 66.6 ± 6.2 | 0.855 |
Hypertension, n (%) | 38 (63.3) | 35 (67.3) | 0.695 |
Diabetes, n (%) | 32 (53.5) | 31 (59.6) | 0.569 |
LVEF, %, mean ± SD | 54.85 ± 6.96 | 54.4 ± 9.0 | 0.843 |
Use of antiplatelet aggregation agents or anticoagulants, n (%) | 58 (96.6) | 51 (98.1) | 0.554 |
Use of statins, n (%) | 57 (95.0) | 50 (96.1) | 0.568 |
Use of ACEI/ARB, n (%) | 38 (63.3) | 34 (65.4) | 0.489 |